Search

Your search keyword '"Cao, X"' showing total 161 results

Search Constraints

Start Over You searched for: Author "Cao, X" Remove constraint Author: "Cao, X" Topic antineoplastic agents Remove constraint Topic: antineoplastic agents
161 results on '"Cao, X"'

Search Results

1. Novel curcumin derivatives N17 exert anti-cancer effects through the CSNK1G3/AKT axis in triple-negative breast cancer.

2. Antibody-Calixarene Drug Conjugate: A General Drug Delivery Platform for Tumor-Targeted Therapy.

3. Dual drug-loaded metal-phenolic networks for targeted magnetic resonance imaging and synergistic chemo-chemodynamic therapy of breast cancer.

4. High affinity and low PARP-trapping benzimidazole derivatives as a potential warhead for PARP1 degraders.

5. The Emerging Role of Deubiquitinases in Radiosensitivity.

6. Recent developments of hydroxamic acid hybrids as potential anti-breast cancer agents.

7. Improving combination cancer immunotherapy by manipulating dual immunomodulatory signals with enzyme-triggered, cell-penetrating peptide-mediated biomodulators.

8. DDR1/2 enhance KIT activation and imatinib resistance of primary and secondary KIT mutants in gastrointestinal stromal tumors.

9. AcGlcAs: A Novel P53-Targeting Arsenical with Potent Cellular Uptake and Cancer Cell Selectivity.

10. Synthesis and biological evaluation of novel quaternary ammonium antibody drug conjugates based on camptothecin derivatives.

11. Promoting Intratumoral Drug Accumulation by Bio-Membrane Regulated Active Targeting for Tumor Photothermal Therapy.

12. The Effects of Drug Exposure and Single Nucleotide Polymorphisms on Aaptinib-Induced Severe Toxicities in Solid Tumors.

13. SPRY4 inhibits and sensitizes the primary KIT mutants in gastrointestinal stromal tumors (GISTs) to imatinib.

14. Design, synthesis, and evaluation of 1H-benzo[d]imidazole-4-carboxamide PARP-1 inhibitors using different saturated nitrogen-contained heterocycle as linker group.

15. Mesoporous nanodrug delivery system: a powerful tool for a new paradigm of remodeling of the tumor microenvironment.

16. Sea Cucumber Derived Triterpenoid Glycoside Frondoside A: A Potential Anti-Bladder Cancer Drug.

17. The STAT family: Key transcription factors mediating crosstalk between cancer stem cells and tumor immune microenvironment.

18. Synthetic Retinoid Kills Drug-Resistant Cancer Stem Cells via Inducing RARγ-Translocation-Mediated Tension Reduction and Chromatin Decondensation.

19. Amphiphilic Aminated Derivatives of [60]Fullerene as Potent Inhibitors of Tumor Growth and Metastasis.

20. Design, semi-synthesis and bioactivity evaluation of novel podophyllotoxin derivatives as potent anti-tumor agents.

21. Recent progress of research on anti-tumor agents using benzimidazole as the structure unit.

22. Cancer Cell Inhibiting Sea Cucumber ( Holothuria leucospilota ) Protein as a Novel Anti-Cancer Drug.

23. Synthesis and evaluation of 2-(4-[4-acetylpiperazine-1-carbonyl] phenyl)-1H-benzo[d]imidazole-4-carboxamide derivatives as potential PARP-1 inhibitors and preliminary study on structure-activity relationship.

24. A tumor microenvironment-responsive poly(amidoamine) dendrimer nanoplatform for hypoxia-responsive chemo/chemodynamic therapy.

25. Digitoxin promotes apoptosis and inhibits proliferation and migration by reducing HIF-1α and STAT3 in KRAS mutant human colon cancer cells.

26. Recent Progress in the Research on Benzimidazole PARP-1 Inhibitors.

27. Tumor-Associated Neutrophil Extracellular Traps Regulating Nanocarrier-Enhanced Inhibition of Malignant Tumor Growth and Distant Metastasis.

28. Au-Fe 3 O 4 nanoagent coated cell membrane for targeted delivery and enhanced chem/photo therapy.

29. Next generation of tumor-activating type I IFN enhances anti-tumor immune responses to overcome therapy resistance.

30. Bottlebrush Polymer-Conjugated Melittin Exhibits Enhanced Antitumor Activity and Better Safety Profile.

31. Sulfarotene, a synthetic retinoid, overcomes stemness and sorafenib resistance of hepatocellular carcinoma via suppressing SOS2-RAS pathway.

32. [Preliminary Efficacy Evaluation of Neoadjuvant Immunotherapy Combined with 
Chemotherapy in Resectable Non-small Cell Lung Cancer].

33. Tumor-associated macrophages-mediated CXCL8 infiltration enhances breast cancer metastasis: Suppression by Danirixin.

34. A cytokine receptor-masked IL2 prodrug selectively activates tumor-infiltrating lymphocytes for potent antitumor therapy.

35. Marine-Derived Macrolides 1990-2020: An Overview of Chemical and Biological Diversity.

36. Self-assembled peptide nanoparticles with endosome escaping permits for co-drug delivery.

38. Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors.

39. Fucoxanthin treatment inhibits nasopharyngeal carcinoma cell proliferation through induction of autophagy mechanism.

40. A simultaneously GSH-depleted bimetallic Cu(ii) complex for enhanced chemodynamic cancer therapy.

41. Immediate Adaptation Analysis Implicates BCL6 as an EGFR-TKI Combination Therapy Target in NSCLC.

42. Casticin inhibits stemness of hepatocellular carcinoma cells via disrupting the reciprocal negative regulation between DNMT1 and miR-148a-3p.

43. Alpha-lipoic acid inhibits lung cancer growth via mTOR-mediated autophagy inhibition.

44. Observation of peroxynitrite overproduction in cells during 5-fluorouracil treatment via a ratiometric fluorescent probe.

45. Patient-derived organoids of non-small cells lung cancer and their application for drug screening.

46. Towards the overcoming of anticancer drug resistance mediated by p53 mutations.

47. Graphene quantum dots: efficient mechanosynthesis, white-light and broad linear excitation-dependent photoluminescence and growth inhibition of bladder cancer cells.

48. Overcoming cisplatin resistance by targeting the MTDH-PTEN interaction in ovarian cancer with sera derived from rats exposed to Guizhi Fuling wan extract.

49. LDH-stabilized ultrasmall iron oxide nanoparticles as a platform for hyaluronidase-promoted MR imaging and chemotherapy of tumors.

50. Precise safety pharmacology studies of lapatinib for onco-cardiology assessed using in vivo canine models.

Catalog

Books, media, physical & digital resources